4Saito A. A putative immunotherapy with biological response modifiers(BRM) againstintractable pulmonary tuberculosis. Kekkaku 2001;76:741.
5Wang CH, Yu CT, Lin HC, et al. HYpodense alveolar macrophages in patientswith diabetes meUitus and active pulmonary tuberculosis. Tuber Lung Dis 1999;79:235.
6Ziv E, Daley CL, Blower SM. Early therapy for latent tuberculosis infection. Am J Epidemiol 2001 ; 153 : 381.
7Trnka L, Dankova D, Krejbich F, et al. Screening of TB contacts by tuberculin skin tests in a low - ncidence community by BCG vaccination. Cent - Eur- J - Public - Health 2001 ;9:26.
8American Thoracic Sosiety: treatment of tuberculosis and tuberculosis infection in adult and children. Am J Respir Crit Care Med 1994;149:1359.
9American Thoracic Society and the Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment if latent tuberculosis infection. Am J Respir Crit Care Med 2000 .161(4Pt2) :S221.
10Perea GC, Torres CA, Vilarreal VH, et al. Progressive age-related changes in pulmonary tuberculosis images and the effect of diabetes. Am J Res Critical Medicine 2000 ; 162 : 1738.
